Fibromyalgia Treatment with Chiropractic

If you suffer with fibromyalgia, you are not alone, as Linton Spine & Joint Chiropractic Center sees many patients with this particular problem in our Mt Sterling chiropractic clinic. As a matter of fact, the Centers for Disease Control and Prevention (CDC) reports that roughly two percent of all adults in the USA have fibromyalgia discomfort. Fortunately, chiropractic care is one treatment option that can provide positive results.

Research Proves Chiropractic Care Eases Fibromyalgia Pain

In a study released in mid-2015, 215 people with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression or anxiety they felt. Then they were split into two groups with one group receiving a multi-modal therapy plan for three months and the second group receiving the same approach plus chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The subjects who received chiropractic treatment in addition to the multi-modal therapy approach reported greater benefits in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study people who received multi-modal treatment without chiropractic adjustments. Additionally, those positive outcomes were long-lasting as the individuals reported continued improvement one full year later.

Fibromyalgia discomfort can greatly reduce your quality of life, both mentally and physically. If you're dealing with fibromyalgia, we might be able to help.

You don't have to suffer! To learn what Linton Spine & Joint Chiropractic Center can do for your fibromyalgia pain, call our Mt Sterling chiropractic office today.

Sources

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.